Articles in Category: More News

Meet us at BIO-Europe in Vienna - Nov. 4-6 2013!

News from Thursday, 31 October 2013.

October 2013

This year we won´t be travelling far, as the annual international partnering conference will be held in Vienna!

We are looking forward to meeting many of you and to take the opportunity to invite you to visit our facility in Baden, just south of Vienna at this occasion!

See you soon, in Vienna!

New Website Launched!

News from Tuesday, 03 September 2013.

September 2013   –  

pharm-analyt officially launched its new website, introducing the updated corporate design


The website was entirely re-engineered to give a quick, yet comprehensive overview of pharm-analyt´s scope of services and special skills. The clear user interface provides easier, more intuitive orientation and efficient navigation. Playful and entertaining aspects take the visitor beyond mere functionality: Encounter curiosity and creativity in a highly regulated environment. The new look and selective use of colors hint at our new corporate design.

New mass-spec System QTRAP® 6500

News from Wednesday, 01 May 2013.

New mass-spec System  QTRAP® 6500

It´s with pride, that pharm-analyt announces the purchase of the new generation mass-spec-system QTRAP® 6500 with SelexION system from AB Sciex!

Meet us at Bio-Europe Spring in Barcelona!

News from Friday, 01 March 2013.

We are looking forward to meeting you at the highly effective partnering conference "Bio-Europe Spring 2013", held in Barcelona in the time between March 11-13th 2013!

We will be delighted to meet with you in a one-to-one partnering meeting or informally at one of the receptions!
And there´s always the opportunity of chatting over a real Austrian cup of coffee and some Mozart-chocolate at the Austrian booth "LISA"! Sounds good?

See you in Barcelona!

Third European Patent for Biomarker Submitted!

News from Tuesday, 01 January 2013.

After submitting european patents for lysosomal storage deseases in 2011 (Gaucher) and 2012 (NPC) in December last year we submitted another patent for a marker for MLD!

All three markers have remarkably high sensitivity as well as specificity.
pharm-analyt is continuously investigating in biomarkers, predominantly Small Molecules in plasma.